USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 36.58 Million | 61.62 Million | 41.35 Million | 29.92 Million | 10.61 Million | 15.07 Million |
Net Income | 6.62 Million | 17.55 Million | -3.18 Million | -22.32 Million | 1.46 Million | 2.45 Million |
Depreciation & Amortization | 25.34 Million | 24.76 Million | 40.76 Million | 34.1 Million | 7.77 Million | 6.9 Million |
Deferred income taxes | 145.71 Thousand | -1.27 Million | -82.86 Million | -385.97 Thousand | -39.1 Thousand | 28.92 Thousand |
Stock-based compensation | 528 Thousand | 651 Thousand | 81 Thousand | 120 Thousand | - | - |
Change in working capital | -3.5 Million | 9.21 Million | -1.6 Million | -10.22 Million | -465.4 Thousand | 4.94 Million |
Other non-cash items | 7.45 Million | 10.71 Million | 88.15 Million | 28.62 Million | 17.89 Million | 9.6 Million |
Investing Cash Flow | -8.38 Million | -3.7 Million | -3.31 Million | -10.94 Million | -10.64 Million | -10.25 Million |
Investments in PPE | -10.8 Million | -4.81 Million | -3.31 Million | -10.94 Million | -10.64 Million | -10.26 Million |
Acquisitions | - | - | - | - | - | 12.39 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 2.42 Million | 1.1 Million | -701.56 Thousand | -2.52 Million | - | - |
Financing Cash Flow | -36.55 Million | -47.73 Million | -30.89 Million | -20.33 Million | -4.84 Million | -238.28 Thousand |
Debt repayment | -422.08 Thousand | -9.42 Million | -4.31 Million | -12.61 Million | -40.67 Million | -238.28 Thousand |
Dividends payments | -1.87 Million | - | - | -2.83 Million | -977.73 Thousand | - |
Common Stock Repurchased | -594.18 Thousand | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 37.15 Million | - |
Other Financing Activities | -6.01 Million | -5.85 Million | -11.41 Million | 7.08 Million | - | - |
Accounts receivables | 1.29 Million | -1.9 Million | 1.68 Million | 7.99 Million | -475.83 Thousand | -4.48 Million |
Accounts payables | -1.81 Million | 11.73 Million | 231.21 Thousand | -17.43 Million | 4.74 Million | 12.8 Million |
Inventory | -3.93 Million | -1.12 Million | -3.16 Million | -1.77 Million | -4.73 Million | -3.37 Million |
Other working capital | 937.12 Thousand | 501.58 Thousand | -361.36 Thousand | 998.98 Thousand | - | - |
Cash at beginning of period | 20.46 Million | 11.51 Million | 8.25 Million | 4.8 Million | 10.21 Million | 5.29 Million |
Cash at end of period | 12.8 Million | 20.46 Million | 11.51 Million | 8.25 Million | 4.8 Million | 10.21 Million |
Capital Expenditure | -10.8 Million | -4.81 Million | -3.31 Million | -10.94 Million | -10.64 Million | -10.26 Million |
Effect of forex changes on cash | 571 Thousand | -137 Thousand | 218 Thousand | 328 Thousand | 0.21 | - |
Net cash flow / Change in cash | -7.65 Million | 8.95 Million | 3.25 Million | 3.45 Million | -5.41 Million | 4.92 Million |
Free Cash Flow | 25.77 Million | 56.8 Million | 38.03 Million | 18.97 Million | -24.77 Thousand | 4.8 Million |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -13.37 Million | -7.07 Million | 17.52 Million | 6.62 Million | 8.59 Million | -9.94 Million |
Depreciation & Amortization | 21.35 Million | 11.06 Million | 7.62 Million | 25.34 Million | 3.52 Million | 16.17 Million |
Deferred income taxes | - | - | 145.71 Thousand | 145.71 Thousand | - | - |
Stock-based compensation | 1212.00 | 1285.71 | 168.4 Thousand | 528 Thousand | 165.19 Thousand | 151.02 Thousand |
Change in working capital | -212.55 Thousand | -16.54 Million | -8.31 Million | -3.5 Million | 15.12 Million | 4.38 Million |
Other non-cash items | 39.87 Million | 15.71 Million | 35.09 Million | 7.45 Million | -14.28 Million | 25.58 Million |
Investing Cash Flow | -3.79 Million | -1.99 Million | -5.21 Million | -8.38 Million | -2.43 Million | -2.89 Million |
Investments in PPE | -4.59 Million | -1.98 Million | -7.63 Million | -10.8 Million | -3.4 Million | -2.89 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 800.42 Thousand | -12.21 Thousand | 2.42 Million | 2.42 Million | 972.68 Thousand | 138.82 Thousand |
Financing Cash Flow | -11.08 Million | -6.09 Million | -23.49 Million | -36.55 Million | -11.33 Million | -11.92 Million |
Debt repayment | -6 Million | - | -5.02 Million | -422.08 Thousand | - | -4.58 Million |
Dividends payments | - | - | -1.87 Million | -1.87 Million | -919.67 Thousand | - |
Common Stock Repurchased | -177.33 Thousand | -93.85 Thousand | -407 Thousand | -594.18 Thousand | -199.71 Thousand | -170.85 Thousand |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -5.65 Million | -5.99 Million | -10.41 Million | -6.01 Million | -10.21 Million | -6.32 Million |
Accounts receivables | -2.21 Million | -1.17 Million | 3.44 Million | 1.29 Million | 1.68 Million | -1.95 Million |
Accounts payables | 31.04 Million | - | -39.12 Million | -1.81 Million | - | 34.06 Million |
Inventory | -28.19 Million | -14.92 Million | 26.25 Million | -3.93 Million | 12.88 Million | -27.55 Million |
Other working capital | -842.93 Thousand | -446.14 Thousand | 1.12 Million | 937.12 Thousand | 549.82 Thousand | -167.41 Thousand |
Cash at beginning of period | 12.8 Million | - | 12.58 Million | 20.46 Million | 12.74 Million | 20.46 Million |
Cash at end of period | 2.98 Million | -4.97 Million | 12.8 Million | 12.8 Million | 12.26 Million | 12.58 Million |
Capital Expenditure | -4.59 Million | -1.98 Million | -7.63 Million | -10.8 Million | -3.4 Million | -2.89 Million |
Effect of forex changes on cash | -34.54 Thousand | -36.64 Thousand | 170.92 Thousand | 571 Thousand | 167.66 Thousand | 173.67 Thousand |
Net cash flow / Change in cash | -9.82 Million | -4.97 Million | 227.77 Thousand | -7.65 Million | -477.71 Thousand | -7.88 Million |
Free Cash Flow | 959.53 Thousand | 1.16 Million | 19.75 Million | 25.77 Million | 9.71 Million | 5.49 Million |
BGIP3
PARAGMILK
BIOFILCHEM
HEERAISP
003013
DCMNVL